Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

PURPOSE: Neoadjuvant chemotherapy for breast cancer provides critical information about tumor response; how best to leverage this for predicting recurrence-free survival (RFS) is not established. The I-SPY 1 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging and...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Esserman, Laura J., Berry, Donald A., DeMichele, Angela, Carey, Lisa, Davis, Sarah E., Buxton, Meredith, Hudis, Cliff, Gray, Joe W., Perou, Charles, Yau, Christina, Livasy, Chad, Krontiras, Helen, Montgomery, Leslie, Tripathy, Debasish, Lehman, Constance, Liu, Minetta C., Olopade, Olufunmilayo I., Rugo, Hope S., Carpenter, John T., Dressler, Lynn, Chhieng, David, Singh, Baljit, Mies, Carolyn, Rabban, Joseph, Chen, Yunn-Yi, Giri, Dilip, van 't Veer, Laura, Hylton, Nola
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2012
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434983/
https://ncbi.nlm.nih.gov/pubmed/22649152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.39.2779
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items